27 Jul 2015

Inzitan (Dexametasona / Lidocaína / Tiamina / Cianocobalamina) - España

ATC: H02AB
SYSTEMIC HORMONAL PREP EXCLUDING SEX HORMONES
CORTICOSTEROIDS FOR SYSTEMIC USE
CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
GLUCOCORTICOIDS
Inzitan

Last Updated on 27 Jul 2015 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

Inzitan Indication

Tratamiento sintomático de patología aguda dolorosa como lumbalgias, ciáticas, lumbociáticas; neuritis, polineuritis.

 

Inzitan Generic Name

Dexametasona / Lidocaína / Tiamina / Cianocobalamina

Type

POM

Summary Product Characteristics (SPCs) Links
Resumen de las Características del Producto - Inzitan (external site)

Related Learning Zones

CSU Knowledge Centre and CME

CSU Knowledge Centre and CME

This Knowledge Centre is intended for allergists, immunologists, dermatologists and other healthcare professionals involved in the treatment and management of Chronic Spontaneous Urticaria (CSU). In the Knowledge Centre, you will find a disease overview, symposium highlights platform, video channel and additional resources including an events calendar and useful external links. This resource has been given a whole new look and feel, intended to improve accessibility and visual appeal. Recent content additions include a frequently asked questions section, case studies from urticaria experts Professor Christian Vestergaard and Professor Torsten Zuberbier and information on the TARGET My Hives app.

Type 2 Diabetes Knowledge Centre and CME

Type 2 Diabetes Knowledge Centre and CME

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

Inzitan Marketing Information

Inzitan Generic Name
Dexametasona / Lidocaína / Tiamina / Cianocobalamina
Marketing Company
KERN PHARMA, S.L.
Drug Type
POM
Date of Issue, Marketing Authority 01/01/1968

Related Drugs - Pain Management

Back to top